Avesthagen’s Teestar® Botanical Chewables Named Finalist For NutraIngredients-Asia 2023 Award Singapore

Teestar® is formulated from an Indian medicinal plant that has traditionally been a part of the food matrix. The recommended dosage for Teestar® is to consume two chewables before breakfast and dinner daily for optimal results. 

Dr. Renuka Jain, President of Avesta Nordic Research Pvt. Ltd., explains that Teestar® forms a colloidal-type suspension in the stomach and intestines upon hydration. This leads to slower gastrointestinal transit and digestion of food, resulting in lesser glucose being absorbed from digested food and a prolonged feeling of satiety.

Teestar® is manufactured in a state-of-the-art production and R&D facility using an eco-friendly and safe extraction process that uses only ethanol and water. Using Avesthagen’s unique fingerprinting method, MetaGrid®, the product’s consistency in quality is maintained.

Event Showcase: Teestar® Botanical Chewables have been selected as a finalist and are scheduled to be showcased at the Nutra Ingredient Asia Show, which will take place at Marina Bay Sands in Singapore on September 26th, 2023. This event aims to highlight Avesthagen’s ‘Food for Medicine’ program, which is focused on the scientific validation of traditional medicine knowledge and natural plant ingredients leading to plant-based medicines for preventive healthcare and treatment of specific disease conditions.

Teestar® Botanical Chewables are promoted as a safe and potent calorie modulator that can assist in managing healthy body mass.

Teestar® is available in two flavors: Litchi and Tamarind, priced at Rs. 750/-. The websites www.avestagoodearthfoods.com, www.amazon.in, and www.1mg.com offer it for sale.

About Avesthagen: 

Avesthagen Limited is an international and diversified life sciences company that follows a systems-biology approach. The company is a pioneer in merging the fields of food, pharmaceuticals, and population genetics to create innovative products and therapies. Avesthagen’s focus lies in bringing its developed products and technologies to the market, with a particular emphasis on Nutrigenomics, Agriculture, and Precision Medicine. They utilize their proprietary Predictive, Preventive, and Personalized (“PPP”) healthcare platform to achieve these goals.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.